author-photo

Nitya Nair

Stanford University

19

Papers

657

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients With Advanced/Metastatic Solid Tumors or Lymphomas.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (73)
A randomized Phase 2b study of GVAX pancreas and CRS-207 compared to chemotherapy in previously-treated metastatic pancreatic adenocarcinoma patients (ECLIPSE Study)

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (75)
Safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
A phase II single-arm study of CRS-207 with pembrolizumab (pembro) in previously treated malignant pleural mesothelioma (MPM).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy for Treatment of Malignant Pleural Mesothelioma

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (31)
Pharmacokinetics, pharmacodynamics, safety, and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans

2017 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (51)
Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

2015 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (42)